Burrill Report: Biotech Innovation Gets the Cash
If the past week is any indication, big pharma is showing that it is willing to pay for biotech innovation.
If the past week is any indication, big pharma is showing that it is willing to pay for biotech innovation.
Data presented this weekend at the American College of Rheumatology’s annual meeting indicated that rheumatoid arthritis patients who adhered to a prescription drug regimen had better medical outcomes and lower medical costs.
Investment website The Motley Fool has published a list of five stocks approaching greatness–and four of them are within the life sciences industry.
That little houseplant sitting on your windowsill could one day save your life.
Copyright © 2024 | WordPress Theme by MH Themes